We found that mRNA levels of PD-1, TIM-3, CTLA-4, TIGIT, CD160, CD244, and KLRG1 were elevated in CRC tumor tissue, implicating their potential contribution to CRC development and/or progression. This evidence concerns the gene CTLA4 and colorectal carcinoma.